EP1171626A4 - FIFTY HUMAN SECRETED PROTEINS - Google Patents
FIFTY HUMAN SECRETED PROTEINSInfo
- Publication number
- EP1171626A4 EP1171626A4 EP00918240A EP00918240A EP1171626A4 EP 1171626 A4 EP1171626 A4 EP 1171626A4 EP 00918240 A EP00918240 A EP 00918240A EP 00918240 A EP00918240 A EP 00918240A EP 1171626 A4 EP1171626 A4 EP 1171626A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12650799P | 1999-03-26 | 1999-03-26 | |
US126507P | 1999-03-26 | ||
US17487200P | 2000-01-07 | 2000-01-07 | |
US174872P | 2000-01-07 | ||
PCT/US2000/007578 WO2000058494A1 (en) | 1999-03-26 | 2000-03-23 | 50 human secreted proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1171626A1 EP1171626A1 (en) | 2002-01-16 |
EP1171626A4 true EP1171626A4 (en) | 2002-10-30 |
Family
ID=26824741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00918240A Withdrawn EP1171626A4 (en) | 1999-03-26 | 2000-03-23 | FIFTY HUMAN SECRETED PROTEINS |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1171626A4 (ja) |
JP (1) | JP2002539841A (ja) |
AU (1) | AU3908600A (ja) |
CA (1) | CA2368719A1 (ja) |
WO (1) | WO2000058494A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020048777A1 (en) | 1999-12-06 | 2002-04-25 | Shujath Ali | Method of diagnosing monitoring, staging, imaging and treating prostate cancer |
FR2819824A1 (fr) * | 2001-01-23 | 2002-07-26 | Molecular Engines Laboratoires | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
IL164376A0 (en) * | 2002-04-03 | 2005-12-18 | Applied Research Systems | Ox4or binding agents, their preparation and pharmaceutical compositions containing them |
CN111467385B (zh) * | 2019-01-24 | 2022-05-17 | 深圳市华大农业应用研究院 | 组合物在预防或治疗神经退行性疾病中的用途 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0607504A1 (de) * | 1992-10-23 | 1994-07-27 | Alfred Kärcher GmbH & Co. | Hochdruckreinigungsgerät |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1998039448A2 (en) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
WO1998040483A2 (en) * | 1997-03-14 | 1998-09-17 | Human Genome Sciences, Inc. | 28 human secreted proteins |
WO1998045712A2 (en) * | 1997-04-08 | 1998-10-15 | Human Genome Sciences, Inc. | 20 human secreted proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5654170A (en) * | 1994-10-12 | 1997-08-05 | Johns Hopkins University | Polycystic kidney disease gene |
US5750370A (en) * | 1995-06-06 | 1998-05-12 | Human Genome Sciences, Inc. | Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor |
-
2000
- 2000-03-23 AU AU39086/00A patent/AU3908600A/en not_active Abandoned
- 2000-03-23 JP JP2000608773A patent/JP2002539841A/ja not_active Withdrawn
- 2000-03-23 EP EP00918240A patent/EP1171626A4/en not_active Withdrawn
- 2000-03-23 CA CA002368719A patent/CA2368719A1/en not_active Abandoned
- 2000-03-23 WO PCT/US2000/007578 patent/WO2000058494A1/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0607504A1 (de) * | 1992-10-23 | 1994-07-27 | Alfred Kärcher GmbH & Co. | Hochdruckreinigungsgerät |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1998039448A2 (en) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
WO1998040483A2 (en) * | 1997-03-14 | 1998-09-17 | Human Genome Sciences, Inc. | 28 human secreted proteins |
WO1998045712A2 (en) * | 1997-04-08 | 1998-10-15 | Human Genome Sciences, Inc. | 20 human secreted proteins |
Non-Patent Citations (8)
Title |
---|
DATABASE EMBL [online] 15 December 1999 (1999-12-15), MATTHEWS L.: "Human DNA sequence from clone RP11-48209 on chromosome 6", XP002208146, Database accession no. AL133507 * |
JACOBS K ET AL: "A NOVEL METHOD FOR ISOLATING EUKARYOTIC CDNA CLONES ENCODING SECRETED PROTEINS", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, WILEY-LISS, US, vol. 21A, 10 March 1995 (1995-03-10), pages 19, XP002027246, ISSN: 0730-2312 * |
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 14, 9 July 1996 (1996-07-09), pages 7108 - 7113, XP002061411, ISSN: 0027-8424 * |
NIELSEN H ET AL: "IDENTIFICATION OF PROKARYOTIC AND EUKARYOTIC SIGNAL PEPTIDES AND PREDICTION OF THEIR CLEAVAGE SITES", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 10, no. 1, 1997, pages 1 - 6, XP002072638, ISSN: 0269-2139 * |
See also references of WO0058494A1 * |
SHIROZU M ET AL: "CHARACTERIZATION OF NOVEL SECRETED AND MEMBRANE PROTEINS ISOLATED BY THE SIGNAL SEQUENCE TRAP METHOD", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 37, no. 3, 1 November 1996 (1996-11-01), pages 273 - 280, XP002054773, ISSN: 0888-7543 * |
TASHIRO K ET AL: "SIGNAL SEQUENCE TRAP: A CLONING STRATEGY FOR SECRETED PROTEINS AND TYPE I MEMBRANE PROTEINS", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 261, 30 July 1993 (1993-07-30), pages 600 - 603, XP000673204, ISSN: 0036-8075 * |
YOKOYAMA-KOBAYASHI M ET AL: "A SIGNAL SEQUENCE DETECTION SYSTEM USING SECRETED PROTEASE ACTIVITY AS AN INDICATOR", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 163, 1995, pages 193 - 196, XP002046435, ISSN: 0378-1119 * |
Also Published As
Publication number | Publication date |
---|---|
EP1171626A1 (en) | 2002-01-16 |
CA2368719A1 (en) | 2000-10-05 |
AU3908600A (en) | 2000-10-16 |
JP2002539841A (ja) | 2002-11-26 |
WO2000058494A1 (en) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1218408A4 (en) | 32 HUMAN, SECRETED PROTEINS | |
EP1212343A4 (en) | 52 HUMAN SECRETED PROTEINS | |
EP1181390A4 (en) | 27 HUMAN SECRETED PROTEINS | |
EP1224285A4 (en) | 27 HUMAN SECRETED PROTEINS | |
EP1212342A4 (en) | 18 HUMAN-SECRETED PROTEINS | |
EP1226231A4 (en) | 19 HUMAN SECRETED PROTEINS | |
EP1175438A4 (en) | 62 HUMANE SECRETIED PROTEINS | |
EP1192278A4 (en) | 48 HUMAN SECRETED PROTEINS | |
EP1192176A4 (en) | 49 HUMAN SECRETED PROTEINS | |
EP1165827A4 (en) | 45 HUMAN SECRETED PROTEINS | |
EP1175439A4 (en) | 49 HUMANE SECRETIED PROTEINS | |
EP1159284A4 (en) | 33 HUMAN SECRETARY PROTEINS | |
EP1189917A4 (en) | 48 HUMAN SECRETED PROTEINS | |
EP1185543A4 (en) | 50 HUMAN-SECRETED PROTEINS | |
EP1224201A4 (en) | 32 HUMAN SECRETED PROTEINS | |
EP1173477A4 (en) | 49 HUMAN SECRETED PROTEINS | |
EP1203005A4 (en) | 25 HUMAN SECRETED PROTEINS | |
EP1206573A4 (en) | 26 HUMAN SECRETED PROTEINS | |
EP1169332A4 (en) | 49 HUMAN SECRETED PROTEINS | |
EP1144614A4 (en) | HUMAN, ELIMINATED PROTEINS | |
EP1171460A4 (en) | 48 HUMAN SECRETED PROTEINS | |
EP1165602A4 (en) | 49 PROTEINS SECRETED BY A HUMAN BEING | |
EP1165828A4 (en) | 50 HUMAN SECRETED PROTEINS | |
EP1228082A4 (en) | HUMAN SECRETED PROTEINS 29 | |
EP1185285A4 (en) | 49 HUMAN SECRETED PROTEINS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011025 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020911 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20021129 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20040505 |